This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| B&M European Value Retail S.A. | 509.8 | 8.0% |
| Endeavour Mining PLC | 2,152.0 | 5.8% |
| Sage Group PLC | 871.0 | 1.7% |
| Astrazeneca PLC | 11,660.0 | 1.4% |
| Auto Trader Group PLC | 630.0 | 1.4% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Prudential PLC | 1,056.0 | -6.1% |
| Ocado Group PLC | 369.0 | -5.8% |
| Entain PLC | 1,319.0 | -4.0% |
| Abrdn PLC | 198.5 | -3.0% |
| Barclays PLC | 151.3 | -2.9% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,446 | -1.0% | -1.2% |
| DOW JONES INDUS. AVG | 32,908 | -0.4% | 0.3% |
| DAX INDEX | 15,664 | -1.5% | 9.2% |
| NIKKEI 225 | 31,148 | 0.8% | 13.4% |
| S&P/ASX 200 INDEX | 7,111 | 0.3% | -1.7% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 68.45 | 0.53% |
| Brent Crude (ICE) | USD/bbl. | 72.66 | -1.20% |
| Gold Spot | USD/t oz. | 1,961 | -0.1% |
| Copper (Comex) | USd/lb. | 368 | 1.3% |
Click graph to enlarge
The UK 100 called to open +20 points at 7464. The UK 100 looks set to open firmer this morning after The House of Representatives passed a bill to raise the US debt ceiling bringing the US closer to avoiding a default. The bill must still pass the Senate and be signed by President Joe Biden to go into effect before the June 5 deadline, but the House vote was seen as the biggest risk. On Wall Street, the Dow Jones fell 134.51 points, to settle at 32,908.27. The S&P gave up 25.53 points to end at 4,179.83 while the Nasdaq Composite ended its winning run, declining 82.14 points, to trade at 12,935.28. In Asia this morning , markets pushed higher. The Nikkei index in Tokyo was up 0.7%. In China, the Shanghai Composite was up 0.3%, while the Hang Seng index in Hong Kong was up 0.8%.
AstraZeneca says Lynparza plus abiraterone have been approved in the US for treatment of prostate cancer.
Autotrader Group reports that their FY Group revenue increased 16% to £500.2m and their FY adjusted EBITDA increased 7% to £328m. The board is confident of meeting its growth expectations for the year.
Pennon Group reported an 88% slump in annual profit due to extreme weather patterns and lower demand during the winter months, at a time when customers were grappling with high power bills. They have allocated £160m for investment in renewable energy generation.
Morgan Stanley Upgrades Convatec to Overweight from Equal weight (9 Buys / 5 Holds / 1 Sell)
UK
Auto Trader Group
Dr Martens
Pennon Group
US
Asana
Broadcom
ChargePoint Holdings
MongoDB
Zscaler
UK
None
US
None
Chinese Caixin Manufacturing PMI
German Retail Sales
German HCOB Manufacturing PMI
UK S&P Global/CIPS Manufacturing PMI
EU Core Harmonized Index of Consumer Prices
EU Harmonized Index of Consumer Prices
EU Unemployment Rate
ECB Monetary Policy Meeting Accounts
US ADP Employment Change
US Initial Jobless Claims
US Initial Jobless Claims 4-week average
US S&P Global Manufacturing PMI
US ISM Manufacturing PMI
UK 100 companies going ex-dividend on 1st June 2023:
National Grid
Severn Trent
Informa
Sage Group
Associated British Foods
Scottish Mortgage Investment Trust
UK 250 companies going ex-dividend on 1st June 2023:
Keller Group
Marshalls
Hilton Food Group
Centamin
Hill & Smith
Great Portland Estates
JLEN Environmental Assets Group
LondonMetric Property
Capital Gearing Trust
Temple Bar Investment Trust
JTC
Law Debenture Corporation
JPMorgan Global Growth & Income
Alliance Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.